Bishal Gyawali: Survival and Quality of Life Should Come Before Platelet Counts
Bishal Gyawali/oncologybg.com

Bishal Gyawali: Survival and Quality of Life Should Come Before Platelet Counts

Bishal Gyawali, Professor at Queen’s University, shared a post on LinkedIn:

“Our goal should be to improve patients survival and quality of life, not just improve their platelet numbers to maintain arbitrarily decided chemo dose.

Our lab’s latest in Nature Reviews Clinical Oncology.”

Title: RECITE this mantra in chemotherapy-induced thrombocytopenia: treat patients, not platelets

Authors: Javier-David Benitez-Fuentes, Laure-Anne Teuwen, Bishal Gyawali

Read the Full Article.

Bishal Gyawali: Survival and Quality of Life Should Come Before Platelet Counts

Other articles featuring Bishal Gyawali.